- Home
- BLRX vs MDRR Comparison
BLRX vs MDRR Comparison
Compare BLRX & MDRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLRX | MDRR |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.1M | 15.0M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BLRX | MDRR |
|---|---|---|
| Price | $3.33 | $13.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 28.9K | 3.9K |
| Earning Date | 11-24-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,735,000.00 | $10,098,461.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.83 |
| 52 Week Low | $2.30 | $9.55 |
| 52 Week High | $14.70 | $15.00 |
Technical Indicators
Market Signals| Indicator | BLRX | MDRR |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 50.52 |
| Support Level | $3.14 | $12.71 |
| Resistance Level | $3.43 | $13.62 |
| Average True Range (ATR) | 0.22 | 0.39 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 26.70 | 37.23 |
Price Performance
Historical ComparisonAbout BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.